US 11702461
T-cell modulatory multimeric polypeptides comprising reduced-affinity immunomodulatory polypeptides
granted A61KA61K2039/605A61K2039/6056
Quick answer
US patent 11702461 (T-cell modulatory multimeric polypeptides comprising reduced-affinity immunomodulatory polypeptides) held by Cue Biopharma, Inc. expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cue Biopharma, Inc.
- Grant date
- Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/605, A61K2039/6056, A61K2039/64, A61K39/12